PEG-MGF
PEG-MGF (Pegylated Mechano Growth Factor) is a modified version of an IGF-1 splice variant that promotes muscle repair and growth. The addition of polyethylene glycol (PEG) extends its half-life in the body, allowing for less frequent administration. Research indicates it plays a significant role in activating muscle stem cells (satellite cells) to repair damage and stimulate tissue regeneration.
01Dosing reference
02Mechanism of action
Satellite Cell Activation
PEG-MGF binds to specific, yet-to-be-fully-characterized receptors on muscle stem cells (satellite cells).
Proliferation and Repair
It stimulates the proliferation of these satellite cells, increasing the pool of cells available for muscle repair and regeneration after injury or exercise.
Neuroprotection and Tissue Healing
Beyond muscle, it has been shown to protect neurons from ischemia and promote healing in various tissues by reducing apoptosis and inflammation.
03Human evidence
Lack of robust human clinical trials
Currently, there are no large-scale, peer-reviewed human clinical trials specifically evaluating the safety and efficacy of PEG-MGF. Most data comes from anecdotal reports or extrapolations from animal models.
04Preclinical evidence
Enhanced muscle regeneration after injury
In rodent models of muscle injury, MGF administration significantly increased the activation of satellite cells and accelerated the repair of damaged muscle fibers.
Neuroprotective effects in ischemia
Animal studies have demonstrated that MGF can protect motor neurons and reduce brain damage following ischemic events (stroke models) by preventing cell death.
05What is known vs. unknown
- PEG-MGF is a pegylated form of Mechano Growth Factor, designed to have a longer half-life than standard MGF.
- It is primarily known for its ability to stimulate the proliferation of muscle satellite cells, aiding in repair.
- Research suggests it has neuroprotective properties, potentially shielding neurons from ischemic damage.
- It is derived from the IGF-1 gene but acts independently of the IGF-1 receptor to promote cell division rather than differentiation.
- The exact receptor that MGF binds to in the body has not been definitively identified.
- Long-term safety and potential side effects in humans are completely unknown due to a lack of clinical trials.
- Optimal dosing protocols and the long-term impact of extended half-life (via pegylation) on tissue homeostasis remain unclear.
06Safety & regulatory context
07Compared with IGF-1 LR3
08Glossary
09Knowledge check
10Sources
More in Healing & Recovery
BPC-157
BPC-157 is a synthetic peptide sequence based on a protective compound naturally found in human gastric juice. Research suggests it has significant regenerative properties, promoting the healing of tendons, ligaments, muscles, and the gastrointestinal tract by accelerating angiogenesis and modulating growth factors.
TB-500 (Thymosin Beta-4)
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research indicates it plays a crucial role in tissue repair, wound healing, and reducing inflammation by upregulating actin, a vital protein for cell structure and movement.
KPV
KPV (Lys-Pro-Val) is a naturally occurring tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Research highlights its potent anti-inflammatory and antimicrobial properties, making it a promising candidate for conditions like inflammatory bowel disease, skin disorders, and wound healing.